Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Endocrine therapies for cancer significantly increase the risk of hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Certain Dibenzo derivatives may help treat prostate cancer.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Some dibenzo compounds might help treat cancer with fewer side effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Bicalutamide may help treat female pattern hair loss.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The new delivery method for dutasteride is more effective and has fewer side effects.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.